Packaging and storage
Preserve in single-dose or multiple-dose containers.
Labeling
Label it to include the following, in addition to the information specified for
Labeling under
Injections 1: the time and date of calibration; the amount of
67Ga as labeled gallium citrate expressed as total megabecquerels (MBq) (microcuries [µCi] or millicuries [mCi]) and concentration as megabecquerels (µCi or mCi) per mL at the time of calibration; the expiration date and time; and the statement CautionRadioactive Material. The labeling indicates that in making dosage calibrations, correction is to be made for radioactive decay, and also indicates that the radioactive half-life of
67Ga is 78.26 hours.
Bacterial endotoxins 85
It meets the requirements of the
Bacterial Endotoxins Test, the limit of endotoxin content being not more than 175/
V USP Endotoxin Unit per mL of the Injection, when compared with the USP Endotoxin RS, in which
V is the maximum recommended total dose, in mL, at the expiration date or time.
Radiochemical purity
Place 10 to 20 µL of Injection about 3 cm from one end of a 3- × 55-cm strip of chromatographic paper (see
Chromatography 621). While spots are wet, immediately develop the chromatogram at room temperature to the 14-cm mark by ascending chromatography, using a solvent system consisting of a mixture of 1.36 g of sodium acetate and 0.58 mL of glacial acetic acid in each 100 mL of water. Allow the strip to partially dry, cover with clear tape, and determine the radioactivity distribution by scanning the chromatogram with a suitable collimated radiation detector: not less than 97.0% of the total radioactivity is found as gallium citrate when measured at the solvent front (
RF value equal to or greater than 0.9).
Radionuclidic purity
Using a suitable counting assembly (see
Selection of a Counting Assembly under
Radioactivity 821), determine the radionuclidic purity of the Injection: not less than 99% of the total radioactivity is present as
67Ga at the time of calibration.
Other requirements
It meets the requirements under
Injections 1, except that the Injection may be distributed or dispensed prior to the completion of the test for
Sterility, the latter test being started on the day of manufacture, and except that it is not subject to the recommendation on
Volume in Container.
Auxiliary Information
Staff Liaison :
Andrzej Wilk, Ph.D., Senior Scientific Associate
Expert Committee : (RMI05) Radiopharmaceuticals and Medical Imaging Agents 05
USP29NF24 Page 985
Pharmacopeial Forum : Volume No. 27(1) Page 1785
Phone Number : 1-301-816-8305